CME Group has appointed Laurent Paulhac to its management team
in New York as managing director for over-the-counter (OTC)
products and services.
He was chief executive of CMA, a provider of credit
derivatives data, which CME bought in 2008. He will stay there
until a replacement CEO is found. Paulhac, 40, will then switch
to leading the development, execution and management of
CME’s OTC business strategy. He will report to
Rick Redding, managing director of products and services.
"Both buy side and sell side clients have indicated their
need for open clearing alternatives in OTC derivatives markets,
particularly in financial products," said Redding.
"Laurent’s experience in credit and interest rate
products will be a tremendous asset to CME Group as we broaden
our OTC offerings and focus on delivering cleared-only
solutions to our OTC clients around the world through CME
Before joining CMA, Paulhac was a management consultant to
venture capital groups and technology companies in financial
services. In 1999, he founded Prescient Markets, an electronic
execution business focused on US money market instruments. In
2002, Prescient Markets was acquired by SunGard Data Systems,
and Paulhac was president of SunGard’s STN Money
Markets division until 2004.
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |